A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke

Archives of Physical Medicine and Rehabilitation

Volumn 90, Issue 9, 2009, Pages 1453-1461

  Meythaler, Jay M ^a   Vogtle, Laura ^b   Brunner, Robert C ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Activities of daily living; Botulinum toxins; Humans; Intramuscular injections; Rehabilitation; Spasticity; Stroke; Therapy

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ADULT; AGED; ARM MOVEMENT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MOTOR ACTIVITY; MOTOR PERFORMANCE; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; STROKE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS, TYPE A; CHRONIC DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PHYSICAL THERAPY MODALITIES; REHABILITATION CENTERS; STROKE;

EID: 69549097906     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2009.02.026     Document Type: Article

References (27)

1. Taub E., Uswatte G., and Morris D.M. Improved motor recovery after stroke and massive cortical reorganization following constraint-induced movement therapy. Phys Med Rehabil Clin N Am 14 1 Suppl (2003) S77-S91 ix
2. Taub E., Miller N.E., Novack T.A., et al. Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil 74 (1993) 347-354
3. Taub E., Crago J.E., Burgio L.D., et al. An operant approach to rehabilitation medicine: overcoming learned nonuse by shaping. J Exp Anal Behav 61 (1994) 281-293
4. van der Lee J.H., Wagenaar R.C., Lankhorst G.J., Vogelaar T.W., Deville W.L., and Bouter L.M. Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial. Stroke 30 (1999) 2369-2375
5. Taub E. Constraint-induced movement therapy and massed practice. Stroke 31 (2000) 986-988
6. Yablon S.A. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders. Phys Med Rehabil Clin N Am 12 (2001) 833-874 vii-viii
7. Simpson D.M. Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve Suppl 6 (1997) S169-S175
8. Brashear A., Gordon M.F., Elovic E., et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 347 (2002) 395-400
9. Wang H.C., Hsieh L.F., Chi W.C., and Lou S.M. Effect of intramuscular botulinum toxin injection on upper limb spasticity in stroke patients. Am J Phys Med Rehabil 81 (2002) 272-278
10. Bakheit A.M., Pittock S., Moore A.P., et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 8 (2001) 559-565
11. Bakheit A.M., Thilmann A.F., Ward A.B., et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 31 (2000) 2402-2406
12. Albany K. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity. Muscle Nerve Suppl 6 (1997) S221-S231
13. Brin M.F. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group. Muscle Nerve Suppl 6 (1997) S208-S220
14. Ashworth B. Preliminary Trial of Carisoprodol in Multiple Sclerosis. Practitioner 192 (1964) 540-542
15. Penn R.D., Savoy S.M., Corcos D., et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320 (1989) 1517-1521
16. Meythaler J.M. Spastic hypertonia. Appendix. Phys Med Rehabil Clin N Am 12 (2001) 953-956 ix
17. Wolf S.L., Catlin P.A., Ellis M., Archer A.L., Morgan B., and Piacentino A. Assessing Wolf motor function test as outcome measure for research in patients after stroke. Stroke 32 (2001) 1635-1639
18. van der Lee J.H., Beckerman H., Knol D.L., de Vet H.C., and Bouter L.M. Clinimetric properties of the motor activity log for the assessment of arm use in hemiparetic patients. Stroke 35 (2004) 1410-1414
19. Law M., and Usher P. Validation of the Klein-Bell activities of daily living scale for children. Can J Occup Ther 55 (1988) 63-68
20. Mahoney F.I., and Barthel D.W. Functional Evaluation: the Barthel Index. Md State Med J 14 (1965) 61-65
21. McHorney C.A., Ware Jr. J.E., Rogers W., Raczek A.E., and Lu J.F. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 30 5 Suppl (1992) MS253-MS265
22. McHorney C.A., Ware Jr. J.E., and Raczek A.E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31 (1993) 247-263
23. Meythaler J.M., Guin-Renfroe S., Brunner R.C., and Hadley M.N. Intrathecal baclofen for spastic hypertonia from stroke. Stroke 32 (2001) 2099-2109
24. Bohannon R.W. Hand-grip dynamometry provides a valid indication of upper extremity strength impairment in home care patients. J Hand Ther 11 (1998) 258-260
25. Downie W.W., Leatham P.A., Rhind V.M., Wright V., Branco J.A., and Anderson J.A. Studies with pain rating scales. Ann Rheum Dis 37 (1978) 378-381
26. Price D.D., Bush F.M., Long S., and Harkins S.W. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 56 (1994) 217-226
27. Levy C.E., Giuffrida C., Richards L., Wu S., Davis S., and Nadeau S.E. Botulinum toxin A, evidence-based exercise therapy, and constraint-induced movement therapy for upper-limb hemiparesis attributable to stroke: a preliminary study. Am J Phys Med Rehabil 86 (2007) 696-706